Curis Lifesciences Share Price NSE Live

Q: What is the current share price of Curis Lifesciences?

The current share price of Curis Lifesciences is ₹94.15.

Q: What sector does Curis Lifesciences operate in?

Curis Lifesciences operates in the sector. Understanding the sector helps investors grasp market trends, which directly influence share prices.

Q: What is the P/E ratio of Curis Lifesciences?

The current P/E ratio of Curis Lifesciences is ₹0. P/E ratio measures Curis Lifesciences share price relative to its earnings per share, offering insight into the company's valuation.

Q: What is the P/B ratio of Curis Lifesciences?

The current P/B ratio of Curis Lifesciences is ₹0. The Price-to-Book (P/B) ratio compares Curis Lifesciences share price to its book value per share, indicating how much investors are willing to pay for each unit of net assets.

Q: What is the 52w high and low of Curis Lifesciences?

The 52-week high of Curis Lifesciences is ₹133.95, and the 52-week low is ₹83.60. These 52-week high and low values help investors assess the stock's price volatility and trading opportunities.

Home

Stocks

Curis Lifesciences

NSE: CURIS

₹94.150.900.97%(1D)

●Open

7 Apr 2026, 03:43 pm

Terminal

Performance Stats for Curis Lifesciences

Day Range

Low: ₹94.15

High: ₹94.15

₹94.15

52 Week Range

Low: ₹83.60

High: ₹133.95

₹94.15

Open Price

94.15

Previous Close

93.25

Volume

1000.00

Open Price

94.15

Previous Close

93.25

Volume

1000.00

Fundamentals of Curis Lifesciences

ROCE

34.13%

EPS

₹7.55

Dividend Yield

P/E Ratio

P/B Ratio

Debt to Equity

1.48

Current Ratio

1.41

Sales Growth

0.00%

Profit Growth

0.00%

EBIT Growth

0.00%

Financials of Curis Lifesciences

All values in Rs. Cr

QTR

Share Holding Pattern of Curis Lifesciences

Promoter

68.03%

Foreign institutions

2.93%

Mutual Funds

0.00%

Other

29.04%

About Curis Lifesciences

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of M/s Loreto Pharmaceutacals, pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter M/s Loreto Ph...